Page 469 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 469

390    Part IV  Disorders of Hematopoietic Cell Development


        and improvement of warts in combination with imiquimod. Immu-  The  translocase  transports  glucose-6-phosphate  into  the  lumen  of
        noglobulin  levels  and  specific  antibody  response  were  not  fully     the endoplasmic reticulum, where it is hydrolyzed into glucose and
        corrected.                                            inorganic phosphate. Absence of translocase results in an inability to
                                                              liberate  glucose  from  glucose-6-phosphate.  Consequently,  patients
                                                              with GSD-1b are susceptible to fasting hypoglycemia, lactic acidosis,
        G6PC3-Associated SCN (Dursun Syndrome)                hepatomegaly,  poor  linear  growth,  delayed  pubertal  development,
                                                              and other systemic complications.
        This  syndrome  is  an  autosomal  recessive  form  of  SCN  caused  by   Most patients have neutropenia, which ranges from mild to severe.
        biallelic  mutant  G6PC3.  Wild-type  G6PC3  encodes  glucose-6-  A strict correlation between genotype and the degree of neutrope-
        phosphatase catalytic subunit 3, which, when mutated, confers an   nia  has  not  been  established.  Some  studies  reported  hypocellular
        increased  susceptibility  of  neutrophils  to  apoptosis.  BM  samples   BM; however, BM testing on nine patients from the City of Hope
        morphology varied among the reported patients, but included mild   National  Medical  Center  in  2001  before  G-CSF  therapy  revealed
        to  moderate  decrease  in  mature  neutrophils,  normal  appearing    normal to hypercellularity in all patients. Maturation arrest at the
        BM  or  promyelocyte-myelocyte  maturation  arrest.  Neutropenia  is   myelocyte stage or later is a feature. Neutrophil apoptosis appears to
        usually  severe,  rendering  patients  susceptible  to  severe  bacterial   be a central mechanism leading to granulopoietic failure. Neutrophil
        infections. Lymphopenia and thrombocytopenia may occur. Struc-  dysfunction with defective chemotaxis and an impaired respiratory
        tural heart defects, urogenital abnormalities, venous angiectasia on   burst is an additional feature. Patients are consequently susceptible
        the  trunk  and  extremities,  intellectual  disability,  inflammatory   to recurrent infections and to inflammatory bowel disease. Infections
        bowel disease, and a broad range of other physical abnormalities are   most commonly involve the skin, perirectal area, ears, and urinary
        additional features. One reported patient developed MDS and sub-  tract,  but  septicemia,  pneumonia,  and  meningitis  may  also  occur.
        sequently AML.                                        The most frequently isolated organisms include Staphylococcus aureus,
                                                              group A streptococci, Streptococcus pneumoniae, Escherichia coli, and
                                                              Pseudomonas.
        Barth Syndrome                                           G-CSF  therapy  is  extremely  effective  in  almost  all  GSD-1b
                                                              patients.  BM  cellularity  increases,  the  ANCs  increase  exuberantly,
        Barth syndrome is a rare multisystem metabolic disorder inherited   and impaired oxygen radical formation is corrected. AML while on
        in an X-linked recessive mode. It is the first human disease in which   G-CSF is a rare event. Prospective data on GSD-1b patients receiving
        the primary causative factor is an alteration of cardiolipin remodeling.   G-CSF therapy from the SCNIR identified 40% with splenomegaly
        Cardiolipin is a component of the inner mitochondrial membrane   before starting G-CSF, 81% with splenomegaly by the first year of
        necessary for proper functioning of the electron transport chain.  treatment, and 100% with splenomegaly by 3 years. Hypersplenism
           The  findings  in  typical  cases  are  mild  to  severe  neutropenia,   can occur but can be overcome by reducing the G-CSF dosage or
        dilated  or  hypertrophic  cardiomyopathy,  underdeveloped  skeletal   by  splenectomy.  Histology  of  the  surgically  excised  spleens  shows
        musculature and muscle weakness, exercise intolerance, growth delay,   extramedullary hematopoiesis.
        cardiolipin  abnormalities,  and  3-methylglutaconic  aciduria.  ANCs
        are variable, but total agranulocytosis has been reported. BM mor-
        phology  includes  a  maturation  arrest  at  the  myelocyte  stage.  On   Other Inherited Neutropenias
        electron microscopy, mitochondria show concentric, tightly packed
        cristae and occasional inclusion bodies in various tissues, including   Other  inherited  neutropenia  disorders  are  associated  with  specific
        granulocyte precursors. Clinically, the cardiomyopathy dominates the   mutant  genes,  but  they  do  not  necessarily  have  the  K/SCN  BM
        clinical  picture,  but  gingivitis,  oral  problems,  and  bacterial  sepsis   phenotype, nor is their pathophysiology necessarily similar (see Table
        from  neutropenia  can  be  problematic.  Most  patients  do  not  need   29.8). Immune  deficiency  appears to  be  an  important  component
        treatment with G-CSF. Anecdotal reports and the authors’ experience   of these syndromes. These miscellaneous forms tend to have distin-
        (Y. Dror, unpublished data) suggest that G-CSF is highly effective in   guishing physical abnormalities such as partial albinism and are not
        correcting  the  neutropenia  and  preventing  infections. The  myriad   predisposed to MDS/AML.
        clinical problems requires a multidisciplinary approach. Female car-
        riers  are  healthy  and  hematologically  normal,  likely  because  of   INHERITED BONE MARROW FAILURE SYNDROMES 
        extreme skewing of X-inactivation. The initial impression that Barth
        syndrome was a lethal infantile disease has been modified; age distri-  WITH PREDOMINANTLY THROMBOCYTOPENIA
        bution  in  54  living  patients  ranges  from  0  to  49  years  and  peaks
        around puberty.                                       Thrombocytopenia With Absent Radii Syndrome
           The  Barth  syndrome  gene  was  mapped  to  Xq28,  which  led
        to  the  cloning  of  the  TAZ  gene  and  the  various  mutations  that   Background
        account for the phenotype. TAZ produces several different mRNAs
        with  resultant  proteins  called  tafazzins.  Mutations  in  TAZ  result   Thrombocytopenia absent radii syndrome has two essential features,
        in  a  decrease  in  tetralinoleoyl  species  of  cardiolipin  and  an  accu-  hypomegakaryocytic  thrombocytopenia  and  bilateral  radial  aplasia
        mulation  of  monolysocardiolipin  within  cells.  A  murine  model  of   with thumbs present. It is one of a group of IBMFSs that includes
        Barth syndrome has been developed. Knocked-down cellular models   FA,  DBA,  and  radioulnar  synostosis  with  radial  ray  anomalies.
        and  patient  BM  cells  are  characterized  by  accelerated  cell  death.   The manifestations of the phenotype vary widely, and patients can
        However,  a  recently  proposed  mechanism  for  the  neutropenia   present with abnormalities involving skeletal, skin, gastrointestinal,
        involves  exposure  of  cell  surface  phosphatidylserine  because  of   brain,  renal,  and  cardiac  systems.  The  identification  of  biallelic
        ROS, and consequently increased clearance of neutrophils by tissue     mutations in RBM8A in patients with TAR syndrome determined
        macrophages.                                          the autosomal recessive inheritance of this disorder. Almost always,
                                                              parents  of  patients  with TAR  are  phenotypically  normal.  Women
                                                              with TAR syndrome can conceive and give birth to hematologically
        Glycogen Storage Disease Type 1b                      and phenotypically normal offspring. Three cases of AML and one
                                                              case  of  acute  lymphoid  (lymphoidic)  leukemia  in  TAR  syndrome
        Glycogen  storage  disease  type  1b  is  caused  by  a  deficiency  in   patients  have  been  reported.  Using  a  denominator  of  about  300
        glucose-6-phosphate  translocase  (transporter)  because  of  mutant   published  cases  of  TAR,  four  leukemic  episodes  (1–2%  crude
        G6PT1 (SLC37A4). GSD-1b patients experience disturbed glucose   rate)  suggests  a  predisposition  to  the  development  of  hematologic
        homeostasis and quantitative or qualitative neutrophil abnormalities.   malignancies.
   464   465   466   467   468   469   470   471   472   473   474